Latest News Archive

Please select Category, Year, and then Month to display items

International Award for UFS Department of Nuclear Medicine

07 July 2023 | Story André Damons | Photo Supplied

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Extending new discoveries in the deep subsurface – UFS paper published in Nature Communications

2015-11-30

Scanning electron microscopy of some of the Eukarya recovered from two different mines. (a) Dochmiotrema sp. (Plathyelminthes), (b) A. hemprichi (Annelida), (c) Mylonchulus brachyurus (Nematoda), (d) Amphiascoides (Arthropoda). Scale bar, 50 µm (a,b), 100 µm (c), 20 µm (d).

Following the discovery of the first Eukarya in the deep subsurface (Nature, 2010) by a research group from the Department of Microbial, Biochemical, and Food Biotechnology at the University of the Free State (UFS) and their international collaborators, intense interest has developed in understanding the diversity of more complex organisms living in these extreme environments.

Prof Gaetan Borgonie from Extreme Life Isyensya, together with a group of UFS researchers, took this research further, resulting in a paper on this research released in Nature Communications – impact factor 11.47. This paper is an extension of the first reports of more complex life at great depths, and their abilities to survive these harsh conditions.

Ten authors from the UFS contributed with the array of expertise needed to define this discovery. The group was supported by staff from the different mining groups, long-term leading collaborators from the USA and Canada, and the idea specialist driver of the paper, Prof Borganie.

“After a sampling campaign that lasted more than two years, we identified that Platyhelminthes, Rotifera, Annelida and Arthropoda are thriving at 1.4 km depths in fissure water up to 12,000-years old in the South African mines of Driefontein and Kopanang,” said Prof Borgonie, who was appointed as associated researcher in the Department of Microbial, Biochemical, and Food Biotechnology.

This paper really opens a “can of worms” so to speak. According to Prof Esta van Heerden from the Department of Microbial, Biochemical and Food Biotechnology at the UFS they extended to define protozoa and fungi. “However, they are present in low numbers,” she said.

Characterisation of the different species reveals that many are opportunistic organisms. In house-adapted video equipment was used to film inside the fissure for the home of the organisms.

This is the first-known study to demonstrate the in situ distribution of biofilms on fissure rock faces using video documentation. Calculations suggest that food, not dissolved oxygen, is the limiting factor for population growth. The discovery of a group of complex multicellular organisms in the underground has important implications for the search for life on other planets in our solar system.

More articles

The strange beasts that live in solid rock deep underground
A microscopic ‘zoo’ is found deep, deep underground

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept